Trial intelligence / Profile preview

Topiramate Prophylaxis as Add-on to Triptan for Migraine

NCT00261469Phase 2Completed

Sponsor
Janssen Ortho
Start
Apr 2003
Modality
Small Molecules
01

Overview

Phase 2, open-label, single-arm trial of topiramate in migraine, sponsored by Janssen Ortho. Primary endpoint: Proportion of migraine attacks that are pain-free two hours after triptan treatment at 2 hours. Started Apr 2003; status: completed.

02

Drugs

topiramate
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00261469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00261469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call